Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kwang Hyub Han

Showing results (251-260 of 527) with videos related to

Pageof 53
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|March 29, 2012
Lamivudine plus adefovir vs. entecavir in HBeAg-positive hepatitis B with sequential treatment failure of lamivudine and adefovirChang Young Son, Han Jak Ryu, Jung Min Lee, et al.
Journal of Gastroenterology and Hepatology|April 16, 2008
Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot studyHyun Woong Lee, Joung Il Lee, Soon Ho Um, et al.
Plos One|July 23, 2013
Association between IL28B polymorphisms and spontaneous clearance of hepatitis B virus infectionSeung Up Kim, Ki Jun Song, Hye Young Chang, et al.
Journal of Gastroenterology and Hepatology|March 23, 2013
Prognostic significance of the worst grade in hepatocellular carcinoma with heterogeneous histologic grades of differentiationDai Hoon Han, Gi Hong Choi, Kyung Sik Kim, et al.
Clinical and Molecular Hepatology|November 25, 2016
Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)Hye Won Lee, Jun Yong Park, Beom Kyung Kim, et al.
Clinical & Experimental Metastasis|February 6, 2014
Prognosis of hepatocellular carcinoma patients with extrahepatic metastasis and the controllability of intrahepatic lesionsJung Il Lee, Ja Kyung Kim, Do Young Kim, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 16, 2015
Inter-observer variability of response evaluation criteria for hepatocellular carcinoma treated with chemoembolizationBeom Kyung Kim, Kyung Ah Kim, Myeong-Jin Kim, et al.
Journal of Korean Medical Science|August 12, 2016
Clinical Utility of a New Automated Hepatitis C Virus Core Antigen Assay for Prediction of Treatment Response in Patients with Chronic Hepatitis CMi Na Kim, Hyon Suk Kim, Ja Kyung Kim, et al.
Hepatology International|July 24, 2015
Consensus cost-effectiveness model for treatment of chronic hepatitis B in Asia Pacific countriesYock Young Dan, John B Wong, Saeed S Hamid, et al.
Journal of Viral Hepatitis|May 5, 2020
Entecavir and tenofovir on renal function in patients with hepatitis B virus-related hepatocellular carcinomaMi Young Jeon, Jae Seung Lee, Hye Won Lee, et al.
Pageof 53

Showing results (251-260 of 527) with videos related to

Sort By:
Pageof 53
Liver International : Official Journal of the International Association for the Study of the Liver|March 29, 2012
Lamivudine plus adefovir vs. entecavir in HBeAg-positive hepatitis B with sequential treatment failure of lamivudine and adefovirChang Young Son, Han Jak Ryu, Jung Min Lee, et al.
Journal of Gastroenterology and Hepatology|April 16, 2008
Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot studyHyun Woong Lee, Joung Il Lee, Soon Ho Um, et al.
Plos One|July 23, 2013
Association between IL28B polymorphisms and spontaneous clearance of hepatitis B virus infectionSeung Up Kim, Ki Jun Song, Hye Young Chang, et al.
Journal of Gastroenterology and Hepatology|March 23, 2013
Prognostic significance of the worst grade in hepatocellular carcinoma with heterogeneous histologic grades of differentiationDai Hoon Han, Gi Hong Choi, Kyung Sik Kim, et al.
Clinical and Molecular Hepatology|November 25, 2016
Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)Hye Won Lee, Jun Yong Park, Beom Kyung Kim, et al.
Clinical & Experimental Metastasis|February 6, 2014
Prognosis of hepatocellular carcinoma patients with extrahepatic metastasis and the controllability of intrahepatic lesionsJung Il Lee, Ja Kyung Kim, Do Young Kim, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 16, 2015
Inter-observer variability of response evaluation criteria for hepatocellular carcinoma treated with chemoembolizationBeom Kyung Kim, Kyung Ah Kim, Myeong-Jin Kim, et al.
Journal of Korean Medical Science|August 12, 2016
Clinical Utility of a New Automated Hepatitis C Virus Core Antigen Assay for Prediction of Treatment Response in Patients with Chronic Hepatitis CMi Na Kim, Hyon Suk Kim, Ja Kyung Kim, et al.
Hepatology International|July 24, 2015
Consensus cost-effectiveness model for treatment of chronic hepatitis B in Asia Pacific countriesYock Young Dan, John B Wong, Saeed S Hamid, et al.
Journal of Viral Hepatitis|May 5, 2020
Entecavir and tenofovir on renal function in patients with hepatitis B virus-related hepatocellular carcinomaMi Young Jeon, Jae Seung Lee, Hye Won Lee, et al.
Pageof 53